Lantern Pharma (LTRN) Operating Expenses (2019 - 2026)
Lantern Pharma's (LTRN) quarterly Operating Expenses came in at $3.4 million in Q1 2026, down 28.67% YoY from $4.8 million in Q1 2025, and down 18.98% on a QoQ basis from $4.2 million in Q4 2025.
Lantern Pharma (LTRN) Operating Expenses (2019 - 2026) Analysis & Trends
Lantern Pharma (LTRN) has 8 years of Operating Expenses data on file, last reported at $3.4 million in Q1 2026.
- Quarterly Operating Expenses fell 28.67% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.6 million (down 21.87% YoY) and the FY2025 annual result came in at $18.0 million, down 19.08% from the prior year.
- Operating Expenses declined to $3.4 million in Q1 2026, from $4.2 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $5.9 million in Q4 2024 to a low of $2.1 million in Q3 2022.
- A 5-year average of $4.5 million and a median of $4.4 million in 2022 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 77.28% in 2022, down 48.29% in 2022.
- Tracing LTRN's Operating Expenses over 5 years: stood at $3.8 million in 2022, then climbed by 27.47% to $4.9 million in 2023, then gained by 20.89% to $5.9 million in 2024, then fell by 28.72% to $4.2 million in 2025, then slipped by 18.98% to $3.4 million in 2026.
- The last three Operating Expenses figures came in at $3.4 million (Q1 2026), $4.2 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Lantern Pharma | 26.11 Mn | 26.11 Mn | - | 3.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.41 Mn |
| Dec 31, 2025 | 4.20 Mn |
| Sep 30, 2025 | 4.35 Mn |
| Jun 30, 2025 | 4.65 Mn |
| Mar 31, 2025 | 4.77 Mn |
| Dec 31, 2024 | 5.90 Mn |
| Sep 30, 2024 | 5.18 Mn |
| Jun 30, 2024 | 5.41 Mn |
| Mar 31, 2024 | 5.73 Mn |
| Dec 31, 2023 | 4.88 Mn |
| Sep 30, 2023 | 3.52 Mn |
| Jun 30, 2023 | 5.19 Mn |
| Mar 31, 2023 | 4.29 Mn |
| Dec 31, 2022 | 3.83 Mn |
| Sep 30, 2022 | 2.15 Mn |
| Jun 30, 2022 | 4.39 Mn |
| Mar 31, 2022 | 4.07 Mn |
| Dec 31, 2021 | 3.51 Mn |
| Sep 30, 2021 | 4.15 Mn |
| Jun 30, 2021 | 2.48 Mn |